Entrada Therapeutics Inc (TRDA)
17.52
+0.06
(+0.37%)
USD |
NASDAQ |
Dec 24, 13:00
17.52
0.00 (0.00%)
After-Hours: 13:01
Entrada Therapeutics Free Cash Flow: -17.46M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Catalyst Pharmaceuticals Inc | 221.79M |
| Vertex Pharmaceuticals Inc | -1.352B |
| Sarepta Therapeutics Inc | -480.40M |
| Regenxbio Inc | -184.74M |
| Edgewise Therapeutics Inc | -110.10M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -24.27M |
| Cash from Investing (Quarterly) | -82.93M |
| Cash from Financing (Quarterly) | -0.011M |
| Free Cash Flow Per Share (Quarterly) | -0.613 |
| Free Cash Flow to Equity (Quarterly) | -24.90M |
| Free Cash Flow to Firm (Quarterly) | -24.90M |
| Free Cash Flow Yield | -2.76% |